Want to join the conversation?
During 2Q16, $FLO's consolidated price/mix fell by 0.5% due to declining price/mix in the non-retail channel, partially offset by positive price/mix in branded retail. Adjusting for pension rederisking settlement in 2Q16 and the asset impairment last year, EPS rose 4% or $0.01 to $0.26. Adjusted EBITDA rose 5.2% to $118.7MM or 12.7% of sales.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?